Werfen USA LLC Therapeutic Drug Monitoring Test Kit VerifyNow® Platelet Reactivity Test Aspirin Assay Whole Blood Sample 10 Tests CLIA Waived - Case of 10 - 00085053-10-CS
Werfen USA LLC Therapeutic Drug Monitoring Test Kit VerifyNow® Platelet Reactivity Test Aspirin Assay Whole Blood Sample 10 Tests CLIA Waived - Case of 10 - 00085053-10-CS
Regular price
$505.99
Sale price
$505.99
Regular price
Unit price
per
Shipping calculated at checkout.
50 In stock
Estimated deliver:
Flat-Rate Shipping from $8.25
Werfen USA LLC Therapeutic Drug Monitoring Test Kit VerifyNow® Platelet Reactivity Test Aspirin A...
| Item Id | 699673 |
| MF Id# | 00085053-10 |
| Brand | VerifyNow® |
| Manufacturer | Werfen USA LLC |
| Country of Origin | United States |
| Application | Therapeutic Drug Monitoring Test Kit |
| CLIA Classification | CLIA Waived |
| CLIA Classified | CLIA Waived |
| Contents 1 | Lyophilized Fibrinogen Coated Beads, Platelet Agonist, Peptide, Bovine Serum Albumin, Stabilizer and Buffer |
| For Use With | For VerifyNow® Instrument |
| Number of Tests | 10 Tests |
| Product Dating | McKesson Acceptable Dating: we will ship >= 60 days |
| Purchase Program Type | Standard Purchase |
| Reading Type | Machine Read |
| Sample Type | Whole Blood Sample |
| Specialty | Chemistry |
| Technology | Light Transmission Aggregometry Technology (LTA) |
| Test Format | Cartridge Format |
| Test Name | Aspirin Assay |
| Test Type | Platelet Reactivity Test |
| Time to Results | 5 Minute Results |
| UNSPSC Code | 41116108 |
Features
- The VerifyNow Aspirin Assay provides a simple measurement to determine whether or not a patient is responding to their aspirin therapy
- The VerifyNow Aspirin Assay is a qualitative assay to aid in the detection of platelet dysfunction due to aspirin ingestion incitrated whole blood for the point of care or laboratory setting
- By measuring the rate and extent of changes in light transmittance caused by platelets aggregating in whole blood samples, the VerifyNow System determines the level of platelet function in response to agonists that are specific to the pathways of various antiplatelet medications
- This assay is not for use in patients with underlying congenital platelet abnormalities, patients with non-aspirin induced acquired platelet abnormalities or in patients receiving non-aspirin antiplatelet agents (may be used in patient s treated with selective COX-2 inhibitors, e.g., celecoxib (Celebrex®)
- Time to results is 5 minutes (sample incubation required)
- Samples should be treated as biohazardous material and handled accordingly
- Store assay devices at 2 °C to 25 °C (36 °-77 °F)